CORONAVIRUS
Clinical trials for CORONAVIRUS explained in plain language.
Never miss a new study
Get alerted when new CORONAVIRUS trials appear
Sign up with your email to follow new studies for CORONAVIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Oxford's COVID shot proves its mettle in major UK trial
⭐️ VACCINE ⭐️ CompletedThis large study tested the Oxford/AstraZeneca COVID-19 vaccine to see if it was safe and effective at preventing illness. Over 10,000 healthy adults in the UK received the vaccine or a control shot and were followed for a year. The main goals were to measure how well it prevente…
Matched conditions: CORONAVIRUS
Phase: PHASE2, PHASE3 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 24, 2026 12:03 UTC
-
Oxford's COVID-19 vaccine put to the test in over 1,000 volunteers
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a new COVID-19 vaccine called ChAdOx1 nCoV-19 to see if it was safe and if it could protect people from getting sick. It involved 1077 healthy adult volunteers in the UK, aged 18 to 55, who received the vaccine as a shot in the arm. The main goals we…
Matched conditions: CORONAVIRUS
Phase: PHASE1, PHASE2 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 18, 2026 14:40 UTC
-
Drugs tested to stop COVID-19 pneumonia from getting worse
Disease control CompletedThis study tested whether two existing anti-inflammatory drugs, ruxolitinib and fostamatinib, could help prevent hospitalized COVID-19 pneumonia patients from getting sicker. The goal was to see if these drugs could stop mild or moderate cases from progressing to severe pneumonia…
Matched conditions: CORONAVIRUS
Phase: PHASE1, PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Can walking help cancer survivors bounce back from COVID?
Symptom relief CompletedThis small, early-stage study tested whether a 30-week personalized walking program is safe for cancer survivors who were previously hospitalized for COVID-19. The main goal was to see if the exercise caused serious side effects. Researchers worked with just a few participants to…
Matched conditions: CORONAVIRUS
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
Blood test clues could flag future COVID-19 crises
Knowledge-focused CompletedThis study aimed to find simple blood markers that could predict which patients arriving at the emergency room with suspected COVID-19 would later get much worse. Researchers followed 373 patients to see if standard blood test results, taken early, could forecast who might need i…
Matched conditions: CORONAVIRUS
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Researchers track 199 hospitalized COVID patients to learn how disease unfolds
Knowledge-focused CompletedThis study aimed to better understand COVID-19 by observing hospitalized adult patients. Researchers collected anonymous medical records from 199 patients to learn about the disease's natural course, what treatments were used, and how patients responded. The study did not test an…
Matched conditions: CORONAVIRUS
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC